|
Insomnia drug therapy in COVID-19 patients; a Letter to Editor
|
Ali Rismanbaf    |
| Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran , alirismanbaf74@gmail.com |
|
|
Abstract: (3613 Views) |
| Coronavirus disease 2019 (COVID-19) is a highly contagious disease caused by the newly emerging SARS-CoV-2 virus that was first reported in December 2019 and was announced as a pandemic disease on March 11th, according to a World Health Organization (WHO) warning (1). SARS-CoV-2 is mainly transmitted through respiratory droplets and close contact, accordingly, requires treatment in isolation. It has been reported that many patients developed sleep disturbances due to isolation treatment or medication use, which can lead to pathological events and impaired immunity, and need to prescribe hypnotic medications (2). Also, some patients may have taken hypnotic medications before developing COVID-19 and may be dependent on these medications, and now, with the onset of COVID-19 and the addition of new drugs for its treatment, they need to change their hypnotic medications. |
|
| Keywords: Coronavirus, Sleep disorder, Hypnotics and Sedatives, Drug therapy |
|
|
Full-Text [PDF 48 kb]
(828 Downloads)
|
Type of Study: Letter to Editor |
Subject:
psychiatry
Received: 2020/03/21 | Accepted: 2020/10/19 | Published: 2017/07/15
|
|
|
|
|
|
